Showing results (171-180 of 221) with videos related to
Sort By:
Pageof 23
Clinical Colorectal Cancer|November 22, 2011
Safety analysis of FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studiesKenichi Sugihara, Atsushi Ohtsu, Yasuhiro Shimada, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trialMace L Rothenberg, P Y Liu, Patricia S Braly, et al.Abdominal Imaging|January 1, 1993
Carcinoid of the intrahepatic ductsR B Gembala, J E Arsuaga, A C Friedman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trialsJ A O'Shaughnessy, R E Wittes, G Burke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2005
Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinomaMace L Rothenberg, Bonnie LaFleur, Donna E Levy, et al.Clinical Pharmacology and Therapeutics|October 7, 2011
Pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-38431055, a novel GPR119 receptor agonist and potential antidiabetes agent, in healthy male subjectsL B Katz, J J Gambale, P L Rothenberg, et al.AJR. American Journal of Roentgenology|June 1, 1986
MRI of hemorrhagic renal cysts in polycystic kidney diseaseP L Hilpert, A C Friedman, P D Radecki, et al.American Journal of Clinical Oncology|December 1, 1994
A phase II trial of DaunoXome, liposome-encapsulated daunorubicin, in patients with metastatic adenocarcinoma of the colonJ R Eckardt, E Campbell, H A Burris, et al.American Journal of Clinical Oncology|April 8, 2006
Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancerAlbert Craig Lockhart, Gillian F Cropp, Jordan D Berlin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Phase I and pharmacokinetic trial of weekly CPT-11M L Rothenberg, J G Kuhn, H A Burris, et al.Pageof 23